Clinical trial Recruiting at 1 site Interventional Ages 20 Weeks to 40 Weeks

Evaluating Sedante Neo Therapy for Low Back Pain Relief

Official title: Effects of Sedante Neo Therapy on Pain, Range of Motion and Quality of Life in Patients With Non Specific Low Back Pain.

Run by Riphah International University · NCT06987175 · Data updated 2026-11-12

This study is testing if Sedante Neo therapy can help people with low back pain feel better and move more easily while improving their quality of life.

Quick facts

Study typeInterventional
Ages20 Weeks to 40 Weeks
SexAll
Enrollment40 (estimated)
SponsorRiphah International University
Academic / other
Locations1 site (Lahore, Punjab Province)
StatusRecruiting
StartedMay 15, 2025
Main results expectedJuly 2025
Study endsJuly 2025
Registry record updatedJuly 4, 2025
Trial IDNCT06987175 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 20 to 40 with non-specific low back pain and specific pain and disability scores.

Probably not a fit

Patients outside the age range of 20 to 40 or those with specific exclusion criteria such as severe underlying conditions will not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effects of Sedante Neo therapy on pain, range of motion, and quality of life in patients suffering from non-specific low back pain. The research aims to provide insights that will assist physiotherapists in developing effective treatment plans. By focusing on a non-pharmacological approach, the study seeks to improve pain management outcomes while minimizing side effects. Participants will engage in Sedante Neo therapy alongside conventional exercises to assess overall effectiveness.

Why it matters

Potential benefit: If successful, this therapy could offer a new, effective non-drug option for managing low back pain.

How similar studies have gone: While similar non-pharmacological approaches have shown promise, the specific efficacy of Sedante Neo therapy remains to be fully established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age group of 20 yeras to 40 years.

  * Both male and female included.
  * Having non-specific low back pain.
  * Having SF-MPQ score 1and 2 (1 means mild, 2 means moderate)
  * Having ODI score 5 to 24
  * Having SF-36 healty survey score below 50
  * Having range of motion below normal.

Exclusion Criteria:

* Below 20 years and above 40 years patient are excluded
* Cervical, knee pain and other conditions excluded.
* Children are excluded
* Red flags ( tuberculosis, carcinoma heart disease etc) excluded

  -Open sores
* Psychiatric diseases such as depression, phobias

  * Patient with history of surgery in lumber region

Where it's running

  • Arthritis and pain care clinic Lahore.
    Lahore, Punjab Province, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.